Production of Chitooligosaccharides and Their Potential Applications in Medicine

被引:463
作者
Aam, Berit B. [1 ]
Heggset, Ellinor B. [2 ]
Norberg, Anne Line [1 ]
Sorlie, Morten [1 ]
Varum, Kjell M. [2 ]
Eijsink, Vincent G. H. [1 ]
机构
[1] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway
[2] Norwegian Univ Sci & Technol, Dept Biotechnol, Norwegian Biopolymer Lab, N-7491 Trondheim, Norway
关键词
chitooligosaccharide (CHOS); chitinase; chitosanase; chitosan; application; LOW-MOLECULAR-WEIGHT; ACETYL-D-GLUCOSAMINE; ACIDIC MAMMALIAN CHITINASE; PLASMODIUM-FALCIPARUM CHITINASE; PLASMA CHITOTRIOSIDASE ACTIVITY; MALARIA PARASITE CHITINASE; CHITOSAN-DNA NANOPARTICLES; FIELD NMR-SPECTROSCOPY; GENE DELIVERY-SYSTEM; X-RAY-STRUCTURE;
D O I
10.3390/md8051482
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Chitooligosaccharides (CHOS) are homo- or heterooligomers of N-acetylglucosamine and D-glucosamine. CHOS can be produced using chitin or chitosan as a starting material, using enzymatic conversions, chemical methods or combinations thereof. Production of well-defined CHOS-mixtures, or even pure CHOS, is of great interest since these oligosaccharides are thought to have several interesting bioactivities. Understanding the mechanisms underlying these bioactivities is of major importance. However, so far in-depth knowledge on the mode-of-action of CHOS is scarce, one major reason being that most published studies are done with badly characterized heterogeneous mixtures of CHOS. Production of CHOS that are well-defined in terms of length, degree of N-acetylation, and sequence is not straightforward. Here we provide an overview of techniques that may be used to produce and characterize reasonably well-defined CHOS fractions. We also present possible medical applications of CHOS, including tumor growth inhibition and inhibition of T(H)2-induced inflammation in asthma, as well as use as a bone-strengthener in osteoporosis, a vector for gene delivery, an antibacterial agent, an antifungal agent, an anti-malaria agent, or a hemostatic agent in wound-dressings. By using well-defined CHOS-mixtures it will become possible to obtain a better understanding of the mechanisms underlying these bioactivities.
引用
收藏
页码:1482 / 1517
页数:36
相关论文
共 183 条
  • [1] Crystal structure of family GH-8 chitosanase with subclass II specificity from Bacillus sp K17
    Adachi, W
    Sakihama, Y
    Shimizu, S
    Sunami, T
    Fukazawa, T
    Suzuki, M
    Yatsunami, R
    Nakamura, S
    Takénaka, A
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2004, 343 (03) : 785 - 795
  • [2] FUNGICIDAL EFFECT OF CHITOSAN ON FUNGI OF VARYING CELL-WALL COMPOSITION
    ALLAN, CR
    HADWIGER, LA
    [J]. EXPERIMENTAL MYCOLOGY, 1979, 3 (03): : 285 - 287
  • [3] Aly MRE, 1998, EUR J ORG CHEM, V1998, P2305
  • [4] Synthesis of chitotetraose and chitohexaose based on dimethylmaleoyl protection
    Aly, MRE
    Ibrahim, ESI
    El Ashry, ESH
    Schmidt, RR
    [J]. CARBOHYDRATE RESEARCH, 2001, 331 (02) : 129 - 142
  • [5] ACTION OF LYSOZYME ON PARTIALLY DEACETYLATED CHITIN
    AMANO, KI
    ITO, E
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1978, 85 (01): : 97 - 104
  • [6] [Anonymous], WHO WORLD MAL REP 20
  • [7] Serum chitotriosidase activity, a marker of activated macrophages, predicts new cardiovascular events independently of C-reactive protein
    Artieda, Marta
    Cenarro, Ana
    Gañan, Alberto
    Lukic, Antonela
    Moreno, Eva
    Puzo, Jose
    Pocovi, Miguel
    Civeira, Fernando
    [J]. CARDIOLOGY, 2007, 108 (04) : 297 - 306
  • [8] Sequence analysis of chitooligosaccharides by matrix-assisted laser desorption ionization postsource decay mass spectrometry
    Bahrke, S
    Einarsson, JM
    Gislason, J
    Haebel, S
    Letzel, MC
    Peter-Katalinic, J
    Peter, MG
    [J]. BIOMACROMOLECULES, 2002, 3 (04) : 696 - 704
  • [9] Bargagli E, 2007, SARCOIDOSIS VASC DIF, V24, P59
  • [10] Plasma chitotriosidase activity in acute Plasmodium falciparum malaria
    Barone, R
    Simporé, J
    Malaguarnera, L
    Pignatelli, S
    Musumeci, S
    [J]. CLINICA CHIMICA ACTA, 2003, 331 (1-2) : 79 - 85